Patent details

EP2648699 Title: TAMPER-RESISTANT DOSAGE FORM

Basic Information

Publication number:
EP2648699
PCT Application Number:
GB2011052455
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP118082866
PCT Publication Number:
WO2012076907
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
TAMPER-RESISTANT DOSAGE FORM
French Title of Invention:
FORME GALÉNIQUE INVIOLABLE
German Title of Invention:
MANIPULATIONSSICHERE PHARMAZEUTISCHE DARREICHUNGSFORM
SPC Number:

Dates

Filing date:
09/12/2011
Grant date:
01/03/2017
EP Publication Date:
16/10/2013
PCT Publication Date:
14/06/2012
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
01/03/2017
EP B1 Publication Date:
01/03/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
09/12/2018
Expiration date:
09/12/2031
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
01/03/2017
 
 

Name:
Euro-Celtique S.A.
Address:
1, rue Jean Piret, 2350 Luxembourg, Luxembourg (LU)

Agent

Name:
MARKS & CLERK LLP
From:
03/04/2017
Address:
BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
To:

Inventor

Name:
MOHAMMAD, Hassan
Address:
United Kingdom (GB)

Priority

Priority Number:
201020895
Priority Date:
09/12/2010
Priority Country:
United Kingdom (GB)

Classification

IPC classification:
A61K 9/00; A61K 9/16; A61K 9/20; A61K 9/50; A61K 31/00; A61K 31/485; A61P 25/04;

Publication

European Patent Bulletin

Issue number:
201709
Publication date:
01/03/2017
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
19/12/2017
Last Annual Fee Paid Number:
7
Last Annual Fee Paid Amount:
82 Euro
Payer:
DENNEMEYER & CO
Filing date Document type Number of pages
30/04/2019 Outgoing Correspondence 1
03/04/2017 Power Of Attorney 1
12/08/2022 Request For Change 1
02/09/2022 Outgoing Correspondence 56